Open AccessHepatotoxicity of Rifampin-Pyrazinamide and Isoniazid Preventive Therapy and Tuberculosis Treatment
Author(s) -
Rob van Hest,
Hubert F. Baars,
Sandra V. Kik,
P. van Gerven,
M.-C. Trompenaars,
Nico Kalisvaart,
Sytze Keizer,
Martien W. Borgdorff,
M. Mensen,
Frank Cobelens
Publication year - 2004
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/422645
Subject(s) - pyrazinamide , medicine , isoniazid , tuberculosis , rifampicin , pharmacology , pathology
Severe liver injury has been attributed to preventive treatment of latent tuberculosis infection with a 2-month course of rifampin-pyrazinamide.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom